Evopoint Biosciences Inc.
Clinical trials sponsored by Evopoint Biosciences Inc., explained in plain language.
-
Race for a better hospital pneumonia drug
Disease control CompletedThis study tested a new antibiotic combination (IMI-XNW4107) against an existing one for treating severe bacterial pneumonia caught in the hospital or while on a ventilator. It involved 450 adult patients to see if the new treatment was at least as good at preventing death within…
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
New pill tested for Tough-to-Treat cancers
Disease control CompletedThis study tested a new oral medication called XNW5004 in patients with advanced lymphoma that had come back or stopped responding to standard treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early signs that…
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC